Antimicrobial activity of a new combination system of benzimidazole and various azoles

Archiv der Pharmazie

Volumn 344, Issue 4, 2011, Pages 264-271

  Özkay, Yusuf ^a   Tunali, Yaǧmur ^a   Karaca, Hülya ^a   Işikdaǧ, Ilhan ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

(Benz)azolylthio; Antimicrobial; Benzimidazole; Brine Shrimp lethality assay; Candida species

Indexed keywords

5,6 DICHLORO 1 METHYL 2 [4 [2 [(1 METHYL 1H 1,2,3,4 TETRAZOL 5 YL)SULFANYL]ACETYLAMINO]PHENYL] 1H BENZIMIDAZOLE; 5,6 DICHLORO 1 METHYL 2 [4 [2 [(1 METHYL 1H IMIDAZOL 2 YL)SULFANYL]ACETYLAMINO]PHENYL] 1H BENZIMIDAZOLE; 5,6 DICHLORO 1 METHYL 2 [4 [2 [(4 METHYL 4H 1,2,4 TRIAZOL 3 YL)SULFANYL]ACETYLAMINO]PHENYL] 1H BENZIMIDAZOLE; 5,6 DICHLORO 1 METHYL 2 [4 [2 [(4H 1,2,4 TRIAZOL 3 YL)SULFANYL]ACETYLAMINO]PHENYL] 1H BENZIMIDAZOLE; 5,6 DICHLORO 1 METHYL 2 [4 [2 [(5 METHYL 1H 1,2,4 THIAZDIAZOL 3 YL)SULFANYL]ACETYLAMINO]PHENYL] 1H BENZIMIDAZOLE; 5,6 DICHLORO 2 [4 [2 [(1 BENZIMIDAZOL 2 YL)SULFANYL]ACETYLAMINO]PHENYL] 1 METHYL 1H BENZIMIDAZOLE; 5,6 DICHLORO 2 [4 [2 [(BENZOTHIAZOL 2 YL)SULFANYL]ACETYLAMINO]PHENYL] 1 METHYL 1H BENZIMIDAZOLE; 5,6 DICHLORO 2 [4 [2 [(BENZOXAZOL 2 YL)SULFANYL]ACETYLAMINO]PHENYL] 1 METHYL 1H BENZIMIDAZOLE; 5,6 DICHLORO [4 [2 [(1 PHENYL 1H 1,2,3,4 TETRAZOL 5 YL)SULFANYL]ACETYLAMINO]PHENYL] 1H BENZIMIDAZOLE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BENZIMIDAZOLE DERIVATIVE; CHLORAMPHENICOL; KETOCONAZOLE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; INFRARED SPECTROSCOPY; KLEBSIELLA PNEUMONIAE; LC 50; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS VULGARIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ARTEMIA; AZOLES; BENZIMIDAZOLES; LETHAL DOSE 50; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE;

EID: 79953769535     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000172     Document Type: Article

References (35)

1. J. Pootoolal, J. Neu, G. D. Wright, Annu. Rev. Pharmacol. Toxicol. 2002, 42, 381-408.
2. D. Abbanat, M. Macielag, K. Bush, Expert Opin. Investig. Drugs 2003, 12, 379-399.
3. I. I. Raad, H. A. Hanna, R. Y. Hachem, T. Dvorak, et al., Antimicrob. Agents Chemother. 2004, 48, 3583-3585.
4. F. W. Goldstein, Clin. Microbiol. Infect. 2007, 13, 2-6.
5. D. F. Fidler, Emerg. Infect. Dis. 1998, 4, 169-177.
6. A. Macchiarulo, G. Constantino, D. Fringuelli, A. Vecchiarelli, et al., Bioorg. Med. Chem. 2002, 10, 3415-3423.
7. H. Goker, C. Kus, D. W. Boykin, S. Yildiz, N. Altanlar, Bioorg. Med. Chem. 2002, 10, 2589-2596.
8. V. Klimesova, J. Koci, M. Pour, J. Stachel, et al., Eur. J. Med. Chem. 2002, 37, 409-418.
9. G. Ayhan-Kilcigil, N. Altanlar, Farmaco 2003, 58, 1345-1350.
10. N. S. Pawar, D. S. Dalal, S. R. Shimpi, P. P. Mahulikar, Eur. J. Pharm. Sci. 2005, 21, 115-118.
11. M. Boiani, M. Gonzalez, Mini Rev. Med. Chem. 2005, 5, 409-424.
12. K. G. Desai, K. R. Desai, Bioorg. Med. Chem. 2006, 14, 8271-8279.
13. B. G. Mohammad, M. A. Hussien, A. A. Abdel-Alim, M. Hashem, Arch. Pharm. Res. 2006, 29, 26-33.
14. O. O. Guven, T. Erdogan, H. Goker, S. Yildiz, Bioorg. Med. Chem. Lett. 2007, 17, 2233-2236.
15. D. Sharma, B. Narasimhan, P. Kumar, A. Jalbout, Eur. J. Med. Chem. 2009, 44, 1119-1127.
16. M. Tuncbilek, T. Kiper, N. Altanlar, Eur. J. Med. Chem. 2009, 44, 1024-1033.
17. A. A. Spasov, I. N. Yozhitsa, L. I. Bugaeva, V. A. Anisimova, Pharm. Chem. J. 1999, 33, 232-243.
18. F. Arjmand, B. Mohani, S. Ahmad, Eur. J. Med. Chem. 2005, 40, 1103-1110.
19. Z. A. Kaplancikli, G. Turan-Zitouni, G. Revial, K. Guven, Arch. Pharm. Res. 2004, 24, 1081-1085.
20. A. Ozdemir, G. Turan-Zitouni, Z. A. Kaplancikli, G. Revial, et al., Enzym. Inhib. Med. Chem. 2010, 25, 565-571.
21. M. Watanabe-Akanuma, T. Ohta, Y. F. Sasaki, Toxicol. Lett. 2005, 158, 213-219.
22. P. Allen, B. Gootlied, Appl. Microbiol. 1970, 20, 919-926.
23. T. C. White, K. A. Marr, R. A. Bowden, Clin. Microbiol. Rev. 1998, 11, 382-402.
24. D. W. Denning, C. C. Kibler, R. A. Barnes, Lancet Infect. Dis. 2003, 3, 230-240.
25. Y. Aoyama, R. J. Sato, J. Biol. Chem. 1984, 259, 1661-1666.
26. D. C. Lamb, D. E. Kelly, K. Venkateswarlu, N. J. Manning, et al., Biochemistry 1999, 38, 8733-8738.
27. F. Giraud, R. Guillon, C. Loge, F. Pagniez, et al., Bioorg. Med. Chem. Lett. 2009, 19, 301-304.
28. J. L. Carballo, Z. L. Hernandez-Inda, P. Perez, M. D. Garcia-Gravalos, BMC Biotechnol. 2002, 2, 17.
29. M. I. Choudhary, W. J. Thomsen, Bioassay Techniques for Drug Development, Harwood Academic Publishers, Amsterdam 2001, pp. 9-10.
30. M. C. Calleja, G. Persoone, ATLA 2002, 20, 396-405.
31. B. Ballantyne, T. C. Marrs, P. Turner, General and Applied Toxicology, 2nd Ed., Vol. I, Wiley, New York 1993, 52.
32. I. Tsakovska, I. Lessigiarska, T. Netzeva, A. Worth, EUR 22486 EN, Review of (Q)SARs for Mammalian Toxicity, European Communities, Brussels 2006.
33. M. M. Hania, Eur. J. Chem. 2009, 6, S508-S514.
34. H. F. Ridley, R. G. W. Spickett, G. M. Timmis, J. Heterocycl. Chem. 1965, 2, 453-456.
35. A. Ozdemir, G. Turan-Zitouni, Z. A. Kaplancikli, Y. Tunali, Enzym. Inhib. Med. Chem. 2009, 24, 825-831.